Catalyst Pharmaceuticals
CPRX
#3888
Rank
C$3.50 B
Marketcap
$29.35
Share price
-3.96%
Change (1 day)
60.13%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): C$0.12 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are C$0.43 Billion. In 2023 the company made an earning of C$0.13 Billion a decrease over its 2022 earnings that were of C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.12 B-5.34%
2023 C$0.13 B-9.75%
2022 C$0.14 B98.83%
2021 C$74.21 M25.73%
2020 C$59.02 M25.38%
2019 C$47.07 M-198.25%
2018 -C$47.92 Million84.68%
2017 -C$25.95 Million1.88%
2016 -C$25.47 Million-10.68%
2015 -C$28.51 Million30.46%
2014 -C$21.86 Million27.6%
2013 -C$17.13 Million198.17%
2012 -C$5.75 Million-36.22%
2011 -C$9.01 Million59.52%
2010 -C$5.65 Million-44.68%
2009 -C$10.21 Million-31.45%
2008 -C$14.89 Million155.21%
2007 -C$5.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$0.55 B 318.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$87.67 M-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.91 B 19,560.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.39 Billion-390.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$1.71 Billion-1,395.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.55 B 7,144.32%๐Ÿ‡บ๐Ÿ‡ธ USA